Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

Item

http://www.wikidata.org/entity/Q26765083

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@ast

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@en

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@nl

type

Item

label

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@ast

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@en

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@nl

prefLabel

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@ast

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@en

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@nl

P1476

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

@en

P2093

Gal Omry-Orbach

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Cancer treatment and survivorship statistics, 2012

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.

P304

e0003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1033893

http://www.w3.org/2001/XMLSchema#string

P356

10.5041/RMMJ.10230

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26886959

http://www.w3.org/2001/XMLSchema#string

P932

4737509

http://www.w3.org/2001/XMLSchema#string